CRLC Val d'Aurelle-Paul Lamarque

Montpellier 34298

0 studies enrolling now · 3 studies all time

What they study most

Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC), Colon Cancer, Hormone Refractory Prostate Cancer, Prostate Cancer

Studies at this site

• TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations — Running, not enrolling
• A Prospective Study for the Assessment of Recurrence Risk in Stage II Colon Cancer Patients Using ColoPrint — Status unconfirmed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed